Target intelligence / Profile preview

Acetyl-CoA acetyltransferase 1 (ACAT1)

Target
ACAT1
Molecular classification
Enzyme, Transferase, Mitochondrial enzyme, Thiolase family (Class II thiolase)
01

Overview

Acetyl-CoA acetyltransferase 1 (ACAT1) is a mitochondrial enzyme and a member of the Class II thiolase family that catalyzes the reversible condensation of two molecules of acetyl-CoA to form acetoacetyl-CoA, a key reaction in ketogenesis and cholesterol biosynthesis[1][5][6][8]. ACAT1 is widely expressed in human tissues and plays an essential role in mitochondrial beta-oxidation of fatty acids, energy metabolism, and maintaining acetyl-CoA homeostasis[1][7][8]. Genetic defects in ACAT1 cause beta-ketothiolase deficiency, which can lead to recurrent episodes of ketoacidosis and other metabolic derangements. ACAT1 is distinct from Acyl-CoA:cholesterol acyltransferases (also sometimes abbreviated as ACAT but encoded by different genes, such as SOAT1 and SOAT2); the canonical name outlined here refers specifically to mitochondrial acetyl-CoA acetyltransferase 1[1][5][8].

Other names
Acetoacetyl-CoA thiolaseThiolase IAcetyl coenzyme A acetyltransferase 1T2 (Thiolase II)mitochondrial thiolase3-ketothiolaseAcetyl coenzyme A C-acetyltransferaseKATBeta-ketothiolase
02

Mechanism of action

Catalyzes the reversible formation of acetoacetyl-CoA from two molecules of acetyl-CoA; drugs would likely act as inhibitors or activators of thiolase activity

03

Biological functions

Fatty acid beta-oxidationKetone body metabolism (ketogenesis and ketolysis)Cholesterol and isoprenoid biosynthesisEnergy productionAcetyl-CoA metabolism
04

Disease associations

Inborn errors of metabolism (e.g., beta-ketothiolase deficiency, a rare metabolic disorder)Neurodegenerative disease (e.g., rare alleles linked to Alzheimer’s disease)Other metabolic diseases
05

Safety considerations

Potential to cause hypoglycemia, acidosis, or metabolic crisis in enzyme deficiency statesInhibition could disrupt energy and lipid metabolism
06

Biomarkers

Elevation of specific organic acids (e.g., 2-methyl-3-hydroxybutyric acid, tiglylglycine) in urine as biomarkers for beta-ketothiolase deficiency

Beyond the preview

Go deeper on Acetyl-CoA acetyltransferase 1 (ACAT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetyl-CoA acetyltransferase 1 (ACAT1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call